UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolic reprogramming underlies cavefish muscular endurance despite loss of muscle mass and contractility

Proceedings of the National Academy of Sciences - PNAS, 2023-01, Vol.120 (5), p.e2204427120

2023

Volltextzugriff (PDF)

The metabolome of Mexican cavefish shows a convergent signature highlighting sugar, antioxidant, and Ageing-Related metabolites

eLife, 2022-06, Vol.11

2022

Volltextzugriff (PDF)

A compiler for biological networks on silicon chips

PLoS computational biology, 2020-09, Vol.16 (9), p.e1008063-e1008063

2020

Volltextzugriff (PDF)

Tellurium notebooks-An environment for reproducible dynamical modeling in systems biology

PLoS computational biology, 2018-06, Vol.14 (6), p.e1006220-e1006220

2018

Volltextzugriff (PDF)

Tellurium: An extensible python-based modeling environment for systems and synthetic biology

BioSystems, 2018-09, Vol.171, p.74-79

2018

Volltextzugriff (PDF)

870 Targeting GCN2 kinase-driven stress response inactivation to restore tumor immunity in metastatic triple negative breast cancer

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A911-A911

2021

Volltextzugriff (PDF)

Synthetic Biology: Engineering Living Systems from Biophysical Principles

Biophysical journal, 2017-03, Vol.112 (6), p.1050-1058

2017

Volltextzugriff (PDF)

libRoadRunner: a high performance SBML simulation and analysis library

Bioinformatics, 2015-10, Vol.31 (20), p.3315-3321

2015

Volltextzugriff (PDF)

Guidelines for Reproducibly Building and Simulating Systems Biology Models

IEEE transactions on biomedical engineering, 2016-10, Vol.63 (10), p.2015-2020

2016

Volltextzugriff (PDF)

libsbmljs—Enabling web-based SBML tools

BioSystems, 2020-07, Vol.195, p.104150-104150, Article 104150

2020

Volltextzugriff (PDF)

Development of BLX-3030, a potent and selective inhibitor of CDK9 for the treatment of NMYC-driven NEPCS

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17067-e17067

2023

Volltextzugriff (PDF)

Kinked again! From congenital brachial plexus palsy to adult neurogenic thoracic outlet syndrome: Case Report

American journal of physical medicine & rehabilitation, 2024-07

2024

Volltextzugriff (PDF)

phraSED-ML: A paraphrased, human-readable adaptation of SED-ML

Journal of bioinformatics and computational biology, 2016-12, Vol.14 (6), p.1650035

2016

Volltextzugriff (PDF)

Enhanced lipogenesis through Pparγ helps cavefish adapt to food scarcity

Current biology, 2022-05, Vol.32 (10), p.2272-2280.e6

2022

Volltextzugriff (PDF)

Abstract LB136: Targeting GCN2 kinase-driven stress response inactivation by orally available small molecules to restore immune tumor microenvironment in prostate cancers

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB136-LB136

2021

Volltextzugriff (PDF)

Fluorescence alteration of MPA capped CdSe quantum dots by spontaneous biomarker protein adsorption

Analytical biochemistry, 2018-08, Vol.555, p.73-80

2018

Volltextzugriff (PDF)

Abstract LB444: Identification of a novel and selective Transglutaminase 2 (TGM2) inhibitors modulate tumor microenvironment in Glioblastoma

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB444-LB444

2024

Volltextzugriff (PDF)

Abstract LB161: Discovery of an oral, potent, and selective CDK9 molecular glue degrader SLX-3065 active in aggressive variant prostate cancers (AVPC)

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB161-LB161

2024

Volltextzugriff (PDF)

Abstract 4649: BLX-3030, a potent, selective, orally available small molecule CDK9 inhibitor for aggressive variant prostate cancers

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4649-4649

2024

Volltextzugriff (PDF)

Abstract C166: Development of BLX-3030, a potent and selective inhibitor of CDK9 for the treatment of N-MYC driven NeuroEndocrine Prostate Cancers (NEPC)

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.C166-C166

2023

Volltextzugriff (PDF)

Abstract LB_C13: Development of BLX-3030, a potent, selective, orally available CDK9i shows promise in Pancreatic Ductal Adenocarcinoma (PDAC) models

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.LB_C13-LB_C13

2023

Volltextzugriff (PDF)

Editorial Reproducibility of Computational Models

IEEE transactions on biomedical engineering, 2016-10, Vol.63 (10), p.1995-1996

2016

Volltextzugriff (PDF)

Footedness, Lateral Dominance and Symmetry in Collegiate Male Soccer Players: 136 June 1, 11

Medicine and science in sports and exercise, 2016-05, Vol.48, p.19

2016

Volltextzugriff (PDF)

A portable structural analysis library for reaction networks

BioSystems, 2018-07, Vol.169-170, p.20-25

2018

Volltextzugriff (PDF)

Abstract LB137: Orally available, CDK9 selective, small molecule inhibitors shows promise in n-Myc-driven neuroendocrine prostate cancers (NEPC)

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB137-LB137

2022

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(30)
Dissertationen
(1)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(11)
Software
(9)
Humans
(8)
Biochemistry & Molecular Biology
(7)
Biology
(7)
Computer Simulation
(7)
Mathematical & Computational Biology
(7)
Systems Biology
(7)
Models, Biological
(6)
Biochemical Research Methods
(5)
Simulation
(5)
Bioengineering
(4)
Life Sciences & Biomedicine - Other Topics
(4)
Physical Sciences
(4)
Reproducibility
(4)
Reproducibility Of Results
(4)
Systems Biology - Methods
(4)
Technology
(4)
Bioinformatics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolic reprogramming underlies cavefish muscular endurance despite loss of muscle mass and contractility

The metabolome of Mexican cavefish shows a convergent signature highlighting sugar, antioxidant, and Ageing-Related metabolites

A compiler for biological networks on silicon chips

Tellurium notebooks-An environment for reproducible dynamical modeling in systems biology

Tellurium: An extensible python-based modeling environment for systems and synthetic biology

870 Targeting GCN2 kinase-driven stress response inactivation to restore tumor immunity in metastatic triple negative breast cancer

Synthetic Biology: Engineering Living Systems from Biophysical Principles

libRoadRunner: a high performance SBML simulation and analysis library

Guidelines for Reproducibly Building and Simulating Systems Biology Models

libsbmljs—Enabling web-based SBML tools

Development of BLX-3030, a potent and selective inhibitor of CDK9 for the treatment of NMYC-driven NEPCS

Kinked again! From congenital brachial plexus palsy to adult neurogenic thoracic outlet syndrome: Case Report

phraSED-ML: A paraphrased, human-readable adaptation of SED-ML

Enhanced lipogenesis through Pparγ helps cavefish adapt to food scarcity

Abstract LB136: Targeting GCN2 kinase-driven stress response inactivation by orally available small molecules to restore immune tumor microenvironment in prostate cancers

Fluorescence alteration of MPA capped CdSe quantum dots by spontaneous biomarker protein adsorption

Abstract LB444: Identification of a novel and selective Transglutaminase 2 (TGM2) inhibitors modulate tumor microenvironment in Glioblastoma

Abstract LB161: Discovery of an oral, potent, and selective CDK9 molecular glue degrader SLX-3065 active in aggressive variant prostate cancers (AVPC)

Abstract 4649: BLX-3030, a potent, selective, orally available small molecule CDK9 inhibitor for aggressive variant prostate cancers

Abstract C166: Development of BLX-3030, a potent and selective inhibitor of CDK9 for the treatment of N-MYC driven NeuroEndocrine Prostate Cancers (NEPC)

Abstract LB_C13: Development of BLX-3030, a potent, selective, orally available CDK9i shows promise in Pancreatic Ductal Adenocarcinoma (PDAC) models

Editorial Reproducibility of Computational Models

Footedness, Lateral Dominance and Symmetry in Collegiate Male Soccer Players: 136 June 1, 11

A portable structural analysis library for reaction networks

Abstract LB137: Orally available, CDK9 selective, small molecule inhibitors shows promise in n-Myc-driven neuroendocrine prostate cancers (NEPC)

Suchergebnisse filtern